FOX vs STRO
Fox Corp Class B (FOX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the FOX and STRO stock pages for the full models.
Not investment advice.